According to a term sheet reviewed by Reuters, Sichuan Kelun-Biotech Pharmaceutical wants to raise $208.6 million in a Hong Kong IPO.
The term sheet stated that the company sells 22.44 million shares at HK$60.60 to HK$72.80 ($7.74-$9.30) each.
The corporation did not immediately respond to Reuters’ request for comment.
The deal’s five cornerstone investors bought $67.3 million in shares.
The term sheet states that the final price will be announced on Tuesday, and the shares will begin trading on the Hong Kong exchange on July 11.
